Short answer
SelectQuote, Inc. (SLQT) filed its Q4 2025 10-Q quarterly report on Feb 5, 2026 for the quarter ended Dec 31, 2025. Quarterly revenue was $537M (up 11.6% year over year) with net income of $69M.
Q4 2025 key financials · XBRL
- Revenue
- $537M
- +11.6% YoY · +63.3% QoQ
- Net income
- $69M
- +30.2% YoY · +327.5% QoQ
- Operating margin
- 14.0%
- EPS (diluted)
- $0.27
- −12.9% YoY · +203.8% QoQ
Source: XBRL data from the SelectQuote, Inc. (SLQT) Q4 2025 10-Q on SEC EDGAR. USD.
SelectQuote, Inc. Q4 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $537.1M, up 12% YoY from $481.1M
- Operating margin 14% vs 15% YoY; net margin 13% vs 11%
- Best performer Pharmacy revenue $227.2M, up 26%; SelectRx members 113,483, up 17%
- Worst performer Commissions and other services revenue $309.9M, up 3%, with six-month revenue down 5%
- Near-term focus SelectRx growth; headwinds included lower Senior LTV per approved policy of $874 vs $907 and 12% lower close rates
Risk Factors
- No material risk-factor changes from the Annual Report
- Carried-forward business risk: known and unknown risks could materially adversely affect operations
- Regulatory compliance risk: securities certifications under Sarbanes-Oxley Sections 302 and 906
- Trading-compliance risk: no officer or director adopted or terminated Rule 10b5-1 arrangements during the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SelectQuote, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.